Stocktoria
Lipocine Inc. LPCN
Lipocine Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M | $11.2M | -$2.9M | $500,000 | $16.1M | $0 | $164,990 | $428,031 | $0 | $0 |
| R&D expense | $8.6M | $7.4M | $10.2M | $8.6M | $7.7M | $9.7M | $7.5M | $6.5M | $11.0M | $8.1M |
| Operating income | -$10.4M | -$1.2M | -$17.9M | -$12.1M | $3.1M | -$18.0M | -$12.9M | -$11.3M | -$21.2M | -$19.2M |
| Interest expense | — | — | — | $27,098 | $203,292 | $386,618 | $766,745 | — | — | — |
| Income tax | $200 | $681 | $755 | $681 | $200 | $200 | $200 | $700 | $700 | $752 |
| Net income | -$9.6M | $8,352 | -$16.4M | -$10.8M | -$634,399 | -$21.0M | -$13.0M | -$11.7M | -$21.0M | -$19.0M |
| EPS (diluted) | $-1.69 | — | $-3.14 | $-2.15 | $-0.01 | $-0.38 | $-0.50 | $-0.55 | $-1.05 | $-1.04 |
| Operating cash flow | -$9.8M | -$1.2M | -$11.9M | -$12.0M | -$4.4M | -$15.3M | -$11.7M | -$12.1M | -$16.7M | -$18.3M |
| Free cash flow | — | -$1.3M | -$11.9M | -$12.1M | -$4.4M | — | — | -$12.1M | -$16.7M | -$18.3M |
| Cash & equivalents | $5.2M | $6.2M | $4.8M | $3.1M | $3.0M | $19.2M | $9.7M | $8.1M | $3.2M | $5.6M |
| Total assets | $17.0M | $22.5M | $23.0M | $37.5M | $52.5M | $25.4M | $19.7M | $20.9M | $25.3M | $27.3M |
| Total liabilities | $2.5M | $1.5M | $2.6M | $1.9M | $6.9M | $10.0M | $13.4M | $11.4M | $6.3M | $1.3M |
| Shareholders' equity | $14.5M | $21.0M | $20.4M | $35.6M | $45.6M | $15.3M | $6.3M | $9.4M | $19.0M | $26.0M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -82.3% | — | -670.2% | -96.9% | — | -100.0% | -61.5% | — | — | — |
| Net income growth | -115371.9% | — | — | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.